MT Group Blog

Filter

Autoimmune Disease Program

July 8, 2024
The MT Group is pleased to announce its Autoimmune Disease (AD) Program, which collects diverse subjects in…

Small Cell Lung Cancer Tissue

July 8, 2024
MT Group's boutique biobank now includes FFPE collected from subjects with small cell lung cancer…

Matched biospecimens (FFPE + plasma) from cancer subjects

July 14, 2023
Are you in need of matched biospecimen sets from cancer subjects? The MT Group has…

Broadened biospecimen collection capabilities for 2023

January 12, 2023
Before the end-of-year cheer is exchanged for 2023’s hecticness, MT Group would like to take…

Optimizing year-end budgets with high value FFPE

September 28, 2022
It is coming up on the end of the year and many MT Group customers…

IO-experienced biospecimens for translational development

July 26, 2022
Are you active in immuno-oncology? If so, you’re not alone - there are now hundreds of…

Comprehensively annotated biospecimens from NASH patients

June 16, 2022
Are you active in non-alcoholic-steatohepatitis (NASH) research?  Maybe you're investigating blood biomarkers for a clinical…

Customized COVID Biospecimen Collections To Power Your R&D

January 11, 2022
Are you working in COVID R&D?  Might you have need for a custom biospecimen collection? …

Customized FFPE tissue collection capabilities

December 7, 2021
Do you work with FFPE tissue? MT Group sites have collected thousands of FFPEs for…